Literature DB >> 7052204

Tissue response to dense apatite implants in rats.

H W Denissen, K de Groot, P C Makkes, A van den Hooff, P J Klopper.   

Abstract

Dense (97-99.9%) hydroxylapatite ceramics were implanted in muscle and bone tissue of rats. The aim of this study was to compare apatite implant material made of commercially available powder with laboratory powder prepared in a painstaking manner. Biocompatibility, biostability, and adherence to bone were evaluated. In muscle tissue the implants were found to be encapsulated with a very thin connective tissue layer. Implantation in excavated bone tissue resulted with new bone directly deposited against the implant surface, irrespective of the type of hydroxylapatite used. When the implants were protruding from the bone surface, bone appeared to grow up to the edge of the protruding part of the implant. A very strong bonding developed; push-out tests indicated that the bone fractured but never at the interface. Histologic studies proved that a sleeve of newly formed bone closely encased the implant, regardless of shape. It was concluded that dense apatite ceramics are fully compatible with the tibia of the rat and that no degradation of the implant material occurred for intervals of up to 6 months after implantation. The very strong bonding without mechanical retention indicated continuity between artificial hydroxylapatite and natural bone. No difference was found between the biological behavior of the hydroxylapatites prepared from commercial or laboratory starting powders.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7052204     DOI: 10.1002/jbm.820140603

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  13 in total

1.  Osseointegration and osseoconductivity of hydroxyapatite of different microporosities.

Authors:  A L Rosa; M M Beloti; P T Oliveira; R Van Noort
Journal:  J Mater Sci Mater Med       Date:  2002-11       Impact factor: 3.896

2.  Cranioplasty with hydroxylapatite ceramic plates that can easily be trimmed during surgery. A preliminary report.

Authors:  T Yamashima
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

3.  Reconstruction of surgical skull defects with hydroxylapatite ceramic buttons and granules.

Authors:  T Yamashima
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

4.  [Release delay of various antibiotics from resorbable tricalcium phosphate ceramic granules with soluble coating for local treatment of osteomyelitis. An animal experiment study].

Authors:  J Eitenmüller; G Peters; W Golsong; R Weltin; G Gellissen; W Reichmann
Journal:  Langenbecks Arch Chir       Date:  1983

Review 5.  [Dental implants and their materials].

Authors:  H Newesely
Journal:  Naturwissenschaften       Date:  1983-07

6.  Search for ideal biomaterials to cultivate human osteoblast-like cells for reconstructive surgery.

Authors:  M Wiedmann-Al-Ahmad; R Gutwald; N-C Gellrich; U Hübner; R Schmelzeisen
Journal:  J Mater Sci Mater Med       Date:  2005-01       Impact factor: 3.896

7.  Nanocrystalline hydroxyapatite for bone repair: an animal study.

Authors:  J Brandt; S Henning; G Michler; W Hein; A Bernstein; M Schulz
Journal:  J Mater Sci Mater Med       Date:  2010-01       Impact factor: 3.896

8.  Study of diopside ceramics for biomaterials.

Authors:  T Nonami; S Tsutsumi
Journal:  J Mater Sci Mater Med       Date:  1999-08       Impact factor: 3.896

9.  Biomimetic nucleation of hydroxyapatite crystals mediated by Antheraea pernyi silk sericin promotes osteogenic differentiation of human bone marrow derived mesenchymal stem cells.

Authors:  Mingying Yang; Yajun Shuai; Can Zhang; Yuyin Chen; Liangjun Zhu; Chuanbin Mao; Hongwei OuYang
Journal:  Biomacromolecules       Date:  2014-03-26       Impact factor: 6.988

10.  Progress and challenges in biomaterials used for bone tissue engineering: bioactive glasses and elastomeric composites.

Authors:  Qizhi Chen; Chenghao Zhu; George A Thouas
Journal:  Prog Biomater       Date:  2012-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.